FN1 and endometrial cancer: In a model of endometrial cancer, it was demonstrated that SPARC activates fibroblasts in the presence of FN1, which itself was secreted by SPARC-expressing endometrial cancer cells, leading to enhanced mobility and invasion (Yoshida et al., 2021).